Información de la revista
Vol. 55. Núm. 6.
Páginas 503-510 (diciembre 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 55. Núm. 6.
Páginas 503-510 (diciembre 2001)
Acceso a texto completo
Utilización de la alternancia de antipiréticos en el tratamiento de la fiebre en España
Use of alternating antipyretics in the treatment of fever in Spain
Visitas
12622
J. Díez Domingoa,
Autor para correspondencia
diez_jav@gva.es

Correspondencia: Dr. J. Díez Domingo.Centro de Salud de Nazaret. Parque, 7B. 46024 Valencia.
, A. Burgos Ramírezb, J. Garrido Garcíab, A. Ballester Sanza, E. Moreno Carreterob
a Centro de Salud de Nazaret.
b Departamento Médico. Laboratorios Knoll. Madrid.
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Objetivo

Analizar la frecuencia de utilización de la administración alternante de antitérmicos entre los pediatras españoles, y los factores que determinan este uso.

Métodos

Se llevó a cabo una encuesta anónima a pediatras en ejercicio activo. Se recogieron los datos de utilización de antitérmicos. Se realizó un análisis de los factores relacionados con la alternancia de antipiréticos con técnicas multivariantes.

Resultados

Se obtuvieron 324 encuestas. La edad media de los participantes fue de 46,4 6 18,6 años (29-68 años de edad). El 22,5 % de los pediatras ejercían en un hospital, el 87,5% en un centro de salud y el 24,7 % tenía su consulta privada. El 68,8 % (IC 95 %, 63,4-73,8 %) utilizaban la pauta alternante de antipiréticos, siendo la combinación de ibuprofeno y paracetamol la recomendada por el 96,9 %. Se relaciona con la utilización secuencial de antitérmicos el hecho de ser varón (OR, 0,535; IC 95 %, 0,296-0,967; p 5 0,038), con pocos años de experiencia (OR, 0,952; IC 95 %, 0,922-0,984; p 5 0,005), considerar el ibuprofeno como fármaco de primera elección (OR, 2,324; IC 95 %, 1,235-4,372; p 5 0,009) y recomendar una nueva dosis de antitérmico ante leves ascensos de temperatura (OR, 0,529; IC 95 %, 0,310-0,901; p 5 0,019).

Conclusiones

A pesar de la falta de evidencia científica que lo justifique, la utilización combinada de antitérmicos es una pauta habitual de tratamiento de la fiebre infantil, siendo factores que predisponen a esta práctica que el pediatra sea varón y con pocos años de ejercicio, que el fármaco utilizado de entrada sea el ibuprofeno, y que se recomiende la utilización de antitérmicos para el tratamiento de fiebre de leve intensidad.

Palabras clave:
Antipiréticos
Utilización alternante
Fiebre
Niños
Objective

To assess the frequency of the use of alternating antipyretics among Spanish pediatricians and to analyze the factors that determine this practice.

Methods

An anonymous survey of practicing pediatricians was conducted. Data on the use of antipyretics were collected Factors related to alternating antipyretics were assessed by using multivariate correlation analyses.

Results

Three hundred twenty-four questionnaires were reviewed. The mean age of participants was 46.4 6 18.6 years (29-68 years). Of the responding pediatricians, 22.5 % worked in hospitals, 87.5 % in health centres and 24.7 % in in private practice. A total of 68.8 % of pediatricians (95 % CI: 63.4-73.8 %) alternated antipyretics. The combination of ibuprofen and acetaminophen was recommended by 96.9%. The use of alternating antipyretics was positively associated with male sex (OR: 0.535; 95% CI: 0.296-0.967; p 5 0.038), with few years experience (OR: 0.952; 95 % CI: 0.922-0.984, p 5 0.005), with considering ibuprofen the drug of choice (OR: 2.324; 95 % CI: 1.235-4.372; p 5 0.009) and with the doctor's recommendation that the antipyretic be readministered in the event of slight increases in temperature (OR: 0.529; 95 % CI:0.310-0.901; p 5 0.019).

Conclusions

Despite the lack of scientific evidence to justify the practice, the use of alternating antipyretics is common in the treatment of febrile children. Predictive factors of this practice among pediatricians are male sex, having relatively little experience, considering ibuprofen as the drug of choice and recommending the administration of new doses of antipyretic to control mild fever.

Key words:
Antipyretics
Alternating doses
Fever
Children
El Texto completo está disponible en PDF
Bibliografía
[1.]
M.J. Kluger.
Drugs for childhood fever [letter].
Lancet, 339 (1992), pp. 70
[2.]
C.M. Verity, N.R. Butler, J. Golding.
Febrile convulsions in a national cohort followed upo from birth, I: prevalence and recurrence in the first year of life.
Br Med J, 290 (1985), pp. 1307-1310
[3.]
J.F. Annegers, S.A. Blakley, W.A. Hauser, L.T. Kurland.
Recurrence of febrile convulsions in a population-based cohort.
Epilepsy Res, 5 (1990), pp. 209-216
[4.]
M.D. Behrmann, R.M. Kliegman, H.B. Jenson.
Saunders WB, (2000),
[5.]
G. Luheshi, N. Rothwell.
Cytokines and fever.
Intern Arch Allergy Immunol, 109 (1996), pp. 301-307
[6.]
C.A. Dinarello.
The endogenous pyrogens in host-defense interactions.
Hosp Pract, 24 (1989), pp. 111-115
[7.]
C.B. Saper, C.D. Breder.
Endogenous pyrogens in the CNS: role in the febrile response.
Prog Brain Res, 93 (1992), pp. 419-428
[8.]
N.J. Roberts.
Impact of temperature elevation on immunologic defenses.
Rev Infect Dis, 13 (1991), pp. 462-472
[9.]
M.S. Kramer, L.E. Naimark, R. Roberts-Brauer, A. McDougall, D.G. Leduc.
Risks and benefits of parcetamol antipyresis in young children with fever of presumed viral origin.
Lancet, 2 (1991), pp. 371-388
[10.]
F. Shann.
Antipyretics in severe sepsis [comment].
Lancet, 345 (1995), pp. 338
[11.]
F.H. Meyers, E. Jawetz, A. Gildfien.
Lange Medical Publications, (1980),
[12.]
M.J. Prior, E.B. Nelson, A.R. Temple.
Pediatric ibuprofen use increases while incidence of Rey' Syndrome continues to decline.
Clin Pediatr, 39 (2000), pp. 245-247
[13.]
P.W. Kandoth, M.K. Joshi, V.R. Joshi, R.S. Satosker.
Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology.
J Int Med Res, 12 (1984), pp. 292-297
[14.]
P.D. Walson.
Ibuprofen versus paracetamol for the treatment of fever in children.
Br J Clin Pract, 44 (1990), pp. 19-21
[15.]
J. Sidler, B. Frey, K. Baerlocher.
A double-blind comparison of ibuprofen and paracetamol in juvenile pyrexia.
Br J Clin Pract, 44 (1990), pp. 22-25
[16.]
R.M. Reekie.
Paediatric ibuprofen —an overview.
Br J Clin Pract, 44 (1990), pp. 12-14
[17.]
L. Bertin, G. Pons, P. D Athis, G. Lasfargues, C. Maudelonde, J.F. Duhamel, et al.
Randomized, double-blind, multicenter, controlled trial of ibuprofen versus acetaminophen (paracetamol) and placebo for treatment of symptoms of tonsillitis and pharyngitis in children.
J Pedriatr, 119 (1991), pp. 811-814
[18.]
Y.K. Amdekar, R.Z. Desai.
Antipyretic activity of ibuprofen and paracetamol in children with pyrexia.
Br J Clin Prac, 39 (1985), pp. 140-143
[19.]
P.D. Walson, G. Galletta, N.J. Braden, L. Alexander.
Ibuprofen, acetaminophen, and placebo treatment of febrile children.
Clin Pharmacol Ther, 46 (1989), pp. 9-17
[20.]
J. Díez Domingo, A. Ballester Sanz.
Utilización secuencial de antitérmicos. ¿Basado en la evidencia o en la costumbre?.
An Esp Ped, 50 (1999), pp. 105-106
[21.]
C.E. Mayoral, R.V. Marino, W. Rosenfeld, J. Greensher.
Alternating antipyretics: is this an alternative?.
Pediatrics, 105 (2000), pp. 1009-1012
[22.]
L.C. Silva.
Muestreo simple aleatorio.
Muestreo para la investigación en ciencias de la salud, pp. 21-59
[23.]
S. Fai Li, B. Lacher, L.F. Crain.
Acetominophen and ibuprofen dosing by parents.
Pediatr Emerg, 16 (2000), pp. 394-397
[24.]
H.C. Mofenson, R. McFae, T. Caraccio, J. Greenaber.
Combined antipyretic therapy: Another potential source of chronic acetaminophen toxicity.
J Pediatr, 133 (1998), pp. 712-713
[25.]
Physicians'Desk Reference, 51.a ed. Medical Economics Company, Inc. (New Jersey) 1997; 1563-1565
[26.]
American Hospital Formulary Service. Drug Information. Bethesda: American Society of Health-System Pharmacist,g 2001; 1917-1923
[27.]
Analgesics and Anti-inflammatory Agents.
Martindale, the Extra Pharmacopoeia, 30.a ed, pp. 17-19
[28.]
E.L. Maunuksela, P. Ryhänen, L. Janhunen.
Efficacy of rectal ibuprofen in controlling postoperative pain in children.
Can J Anaesth, 39 (1992), pp. 226-230
[29.]
B.H. Wallace, F.T. Caldwell, J.B. Cone.
Ibuprofen lowers body temperature and metabolic rate of humans with burn injury.
J Trauma, 32 (1992), pp. 154-157
[30.]
H. Kokki, H. Hendolin, E.L. Maunuksela, J. Vainio, L. Nuutinen.
Ibuprofen in the treatment of postoperative pain in small children. A randomized double-blind-placebo controlled parallel group study.
Acta Anaesthesiol Scand, 38 (1994), pp. 467-472
[31.]
P.D. Walson, G. Galleta, F. Chamilo, N.J. Braden, L.A. Sawyer, M.L. Scheinbaum.
Comparison of multidose ibuprofen and acetaminophen therapy in febrile children.
Am J Dis Child, 146 (1992), pp. 626-632
[32.]
A. Kotob.
A comparative study of two dosage levels of ibuprofen syrup in children with pyrexia.
J Int Med Res, 13 (1985), pp. 122-126
[33.]
E.H. Giannini, E.J. Brewer, M.L. Miller, D. Gibbas, M.H. Passo, H.M. Hoyeraal, et al.
Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis.
J Pediatr, 117 (1990), pp. 645-652
[34.]
A. Steans, P.J. Manners, I.G. Robinson.
A multicentre, long-term evaluation of the safety and efficacy of ibuprofen syrup in children with juvenile chronic arthritis.
Br J Clin Pract, 44 (1990), pp. 172-175
[35.]
M.W. Konstan, P.J. Byard, C.L. Hoppel, P.B. Davis.
Effect of high-dose ibuprofen in patients with cystic fibrosis.
N Engl J Med, 332 (1995), pp. 848-854
[36.]
S.M. Lesko, A.A. Mitchell.
An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial.
J Am Med Assoc, 273 (1995), pp. 929-933
[37.]
G. Wilson, A.J.M.S. Guerra, N. Teixeira Santos.
Teixeira Santos N. Comparative study of the antipyretic effect of ibuprofen (oral suspension) and paracetamol (suppositories) in paediatrics.
J Int Med Res, 12 (1984), pp. 46-49
[38.]
G. Heremans, F. Dehaen, N. Rom, J. Ramet, M. Verboven, H. Loeb.
A single-blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children.
Br J Clin Prac, 42 (1988), pp. 245-247
[39.]
J.T. Wilson, R. Don Brown, G.L. Kearns, V.F. Eichler, V.A. Johnson, K.M. Bertrand, et al.
Single-dose, placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children.
J Pediatr, 119 (1991), pp. 803-811
[40.]
J. McIntyre, D. Hull.
Comparing efficacy and tolerability of ibuprofen and paracetamol in fever.
Arch Dis Child, 74 (1996), pp. 164-167
[41.]
J. Díez-Domingo, M.V. Planelles, J.M. Baldó, A. Ballester, F. Núñez, A. Jubert, et al.
Ibuprofen profilaxis for adverse reactions to diptheria-tetanus-pertussis vaccination: a randomized trial.
Curr Ther Res, 59 (1998), pp. 579-588
[42.]
E. Ashraf, L. Ford, R. Geetha, S. Cooper.
Safety profile of ibuprofen suspension in young children.
Inflammopharmacology, 7 (1999), pp. 219-225
[43.]
A. Varvarigou, C.L. Bardin, K. Beharry, S. Chemtob, A. Papageorgiu, J.V. Aranda.
Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.
J Am Med Assoc, 275 (1996), pp. 539-544
[44.]
B. Van Overmeire, I. Follens, S. Hartmann, W.L. Creten, K.J.V. Van Acker.
Treatment of patent ductus arteriosus with ibuprofen.
Arch Dis Child, 76 (1997), pp. 179-184
[45.]
J.V. Aranda, A. Varvarigou, K. Beharry, R. Bansal, C. Bardin, H. Modanlou, et al.
Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant.
Acta Pædiatr, 86 (1997), pp. 289-293
[46.]
F. Mosca, M. Bray, M. Lattanzio, M. Fumagalli, C. Tosetto.
Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus.
J Pediatr, 131 (1997), pp. 549-554
[47.]
C. Dani, G. Bertini, M.F. Reali, P. Murru, C. Fabris, V. Vangi.
Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants.
Acta Pædiatr, 89 (2000), pp. 1369-1374
[48.]
K. Van Overmeire Smets, D. Lecutere, H. Van de Broek, J. Weyler, K. De Groote, J.P. Langhendries.
A comparison of ibuprofen and indometacin for closure of patent ductus arteriors.
N Engl J Med, 343 (2000), pp. 674-681
[49.]
B.D. Schmitt.
Fever phobia.
Am J Dis Child, 134 (1980), pp. 176-181

Este estudio ha sido financiado por Laboratorios Knoll, S.A., Madrid, España

Copyright © 2001. Asociación Española de Pediatría
Descargar PDF
Idiomas
Anales de Pediatría
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?